Furthermore, we confirmed that a new UBE2T inhibitor M435-1279 could effectively suppress GC progression with lower cytotoxicity by blocking the hyperactivation of the Wnt/β-catenin signaling pathway in the meantime. Here, UBE2T is linked to gastric cancer.